U.S. Specialty Stores Stock News

Veracyte recently announced that more than 15 studies on its Decipher prostate and bladder cancer diagnostics were presented at the 2026 American Urological Association Annual Meeting, underscoring the role of these genomic tests in guiding personalized urologic cancer care. The breadth of real-world and molecular subtyping data around the Decipher portfolio highlights how Veracyte’s GRID platform is becoming an important engine for evidence generation in urologic oncology. Next, we’ll...

Versant Media Group (VSNT) has been drawing attention after recent share price moves, with the stock up around 13% over the past month and about 20% over the past 3 months. See our latest analysis for Versant Media Group. At a latest share price of $39.90, Versant Media Group’s recent 30 day share price return of 12.62% and 90 day share price return of 20.29% contrast with a year to date share price return decline of 14.47%, suggesting momentum has picked up again in the short term. If this...

On 20 April 2026, Rumble Inc. launched the OpenClaw Starter package on Rumble Cloud, a pre-configured hosted environment that bundles compute, storage, networking, a web interface, and guided onboarding so users can deploy personal AI agents with optional Telegram integration on independent infrastructure. The package is the first hosted environment to ship with MoonPay’s crypto-enabled Agent pre-loaded, tying Rumble’s cloud and AI ambitions directly into MoonPay’s Open Wallet Standard and...

If you are wondering whether Ameren at around US$111.91 is still reasonably priced or starting to look stretched, the answer depends on how you look at value. The stock has returned 0.6% over the past week, 2.9% over the past month, 11.0% year to date, 16.4% over 1 year, 37.0% over 3 years, and 52.1% over 5 years. These performance figures naturally get investors thinking about both growth potential and changing risk. Recent attention on regulated utilities, including Ameren, has centered on...

FirstCash Holdings (FCFS) drew fresh attention after announcing a US$600 million private placement of senior notes, along with first quarter 2026 results showing higher revenue and net income compared with a year earlier. See our latest analysis for FirstCash Holdings. At a share price of US$217.35, FirstCash has seen firm momentum build recently, with a 30 day share price return of 13.87% and a year to date gain of 38.63%, while the 1 year total shareholder return of 65.61% and 5 year total...

How Chesapeake Utilities stock has been performing Chesapeake Utilities (CPK) has drawn attention after recent price moves, with the stock last closing at $127.05. Short term returns have been mixed, and year to date performance sits just above 2%. Over the past month, the share price shows a gain of about 2%, while the past 3 months reflect a slight negative total return. Over a longer horizon, reported total return figures over 3 and 5 years indicate positive compounding for investors. See...

Taysha Gene Therapies recently reported preclinical in vitro data showing its self-complementary AAV9 vector produced roughly 30-fold higher MeCP2 protein expression than a single-stranded AAV9 approach, while its miniMeCP2 construct maintained stable, functional expression in neuronal cells. These findings add biological support for the design of TSHA-102 in Rett syndrome and offer additional translational evidence backing its ongoing Phase 1/2 clinical trials. Next, we’ll examine how this...

Sirius XM Holdings (NasdaqGS:SIRI) is reported to be in early merger talks with iHeartMedia. The discussions focus on combining satellite radio, streaming audio, and terrestrial broadcast under one company. The talks are described as preliminary, with no confirmed transaction terms or timeline. Sirius XM Holdings operates subscription based satellite radio and audio streaming services, while iHeartMedia runs a large portfolio of terrestrial radio stations and digital audio platforms. A...

Arqit Quantum (ARQQ) has been selected as a Scaleup Partner in the Tomorrow Street portfolio, following its involvement in the Scaleup X programme. This development is putting fresh attention on how its quantum cybersecurity offering fits current market expectations. See our latest analysis for Arqit Quantum. At a share price of $14.58, Arqit Quantum’s 23.77% 1 month share price return contrasts with a 40.59% year to date share price decline and a 94.02% 5 year total shareholder return loss...

Recent performance snapshot for Cheniere Energy Partners (CQP) Cheniere Energy Partners (CQP) has drawn investor attention after a mixed stretch in its liquefied natural gas operations, with annual revenue of US$10.76b alongside net income of US$2.50b and moderate year on year growth figures. See our latest analysis for Cheniere Energy Partners. At a share price of US$62.73, Cheniere Energy Partners has seen a 16.17% year to date share price return and a 10.29% total shareholder return over...

If you are wondering whether Sanmina's share price still offers value or if the easy gains are behind it, the starting point is to look closely at what the current price implies about the business. At a last close of US$188.08, Sanmina has recorded returns of 7.2% over the past week, 43.7% over the past month, 18.1% year to date and 133.0% over the past year, which naturally raises questions about growth potential and how much risk is now priced in. This article was triggered to provide...

Brixmor Property Group Inc. has reported its first-quarter 2026 results, with revenue of US$354.82 million and net income of US$127.75 million, alongside basic earnings per share from continuing operations of US$0.42, all above the prior year’s levels. The company also delivered funds from operations that exceeded analyst expectations, raised its 2026 Nareit FFO and same-property NOI outlook, and declared a quarterly cash dividend, underscoring stronger leasing activity and operational...

In the past week, The Bancorp, Inc. reported first-quarter 2026 results showing net income of US$60.07 million and diluted EPS of US$1.41, alongside lower net charge-offs and the completion of a US$50.00 million buyback covering 843,061 shares. Management also reaffirmed 2026 EPS guidance of US$5.90, introduced a 2027 EPS range of US$8.10–US$8.30, and highlighted rapid growth in fintech-related credit sponsorship balances to US$1.65 billion, reflecting a continued shift toward higher-return,...

The United States market remained flat over the last week but has experienced a significant 30% increase over the past year, with earnings forecasted to grow by 16% annually. In such an environment, identifying stocks that are trading below their intrinsic value can present opportunities for investors seeking potential gains while aligning with projected growth trends.

Pinnacle West Capital Corporation recently declared a quarterly dividend of US$0.9100 per share, payable on June 1, 2026, to shareholders of record as of the May 4, 2026 ex-dividend and record date. Alongside this dividend affirmation, analysts are highlighting a positive Earnings ESP and a neutral Zacks Rank, pointing to rising expectations around the upcoming earnings release. Next, we’ll examine how optimism around a potential earnings beat may influence Pinnacle West Capital’s existing...

In the last week, the market has stayed flat, yet it is up 30% over the past year with earnings forecast to grow by 16% annually. In this environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and adaptability within a rapidly evolving sector.

Kestra Medical Technologies (KMTS) has drawn investor attention after recent trading left the shares around $22.23, with a mixed return profile across the past week, month and past 3 months. See our latest analysis for Kestra Medical Technologies. The recent 14.23% 1 month share price return contrasts with weaker year to date share price performance of 8.86% and a 1 year total shareholder return of 11.50%. This suggests short term momentum has picked up while longer term returns remain under...

ZTO Express (Cayman) (ZTO) stock has drawn fresh attention after recent trading, with shares last closing at $25.42. Readers are weighing this move against its performance over the past month and the previous three months. See our latest analysis for ZTO Express (Cayman). That 1 month share price return of 5.65% builds on a 90 day share price return of 17.25%, while the 1 year total shareholder return of 36.83% suggests momentum has been gaining rather than fading. If recent moves in ZTO have...

Oppenheimer Holdings Inc. disclosed that its main subsidiary, Oppenheimer & Co. Inc., agreed to a US$70,000,000 class-action settlement over its FDIC-insured cash sweep program, subject to final court approval and booked as a first-quarter 2026 charge. The settlement caps a case where plaintiffs had indicated they might seek more than US$440,000,000 in damages, sharply reducing legal uncertainty while leaving Oppenheimer without any admission of wrongdoing. We will now examine how...

The United States market remained flat over the last week but has seen a notable 30% increase over the past year, with earnings forecasted to grow by 16% annually. In such an environment, growth companies with high insider ownership can be particularly appealing as they often signal strong internal confidence and alignment with shareholder interests.

In late March, Wedbush downgraded Burford Capital to Neutral after a U.S. Appeals Court decision in the YPF case prompted the company to flag that fair value marks could affect its net worth requirements and access to debt financing. Deutsche Bank, however, maintained a positive stance on Burford’s long-term prospects, highlighting that legal and balance sheet uncertainties around YPF are now central to how investors assess the business. We’ll now look at how heightened concern over net...

In the last week, the U.S. market has stayed flat, but over the past 12 months, it has risen by 30%, with earnings expected to grow by 16% per annum in the coming years. Amidst these conditions, identifying stocks with solid fundamentals and growth potential is crucial for investors looking to capitalize on market opportunities. Penny stocks may be an outdated term, but they still represent a valuable investment area; when backed by strong financials and balance sheet strength, these smaller...

The United States market has experienced a flat performance over the last week but has seen a significant 30% increase over the past year, with earnings projected to grow by 16% annually. In this dynamic environment, identifying stocks that combine strong fundamentals and growth potential can be key to uncovering hidden opportunities in the market.

Veradermics (NYSE:MANE) reported positive topline data from its pivotal Phase 2/3 trial of VDPHL01, an investigational non-hormonal oral treatment for pattern hair loss. The company framed VDPHL01 as a potential first in class oral option that could lead to the first FDA approval for a non-hormonal hair loss pill in nearly 30 years. Following the clinical update, Veradermics launched a proposed public offering tied to this stage of clinical and corporate progress. Veradermics focuses on...